Free Trial

WCM Investment Management LLC Sells 1,075,962 Shares of DocGo Inc. (NASDAQ:DCGO)

DocGo logo with Medical background

WCM Investment Management LLC decreased its stake in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) by 24.9% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 3,238,109 shares of the company's stock after selling 1,075,962 shares during the period. WCM Investment Management LLC owned 3.18% of DocGo worth $8,549,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in DCGO. Summit Investment Advisors Inc. lifted its holdings in DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock worth $45,000 after purchasing an additional 2,968 shares in the last quarter. Prudential Financial Inc. purchased a new stake in DocGo during the 4th quarter worth about $55,000. Royce & Associates LP purchased a new stake in DocGo during the 4th quarter worth about $64,000. Boothbay Fund Management LLC lifted its holdings in DocGo by 154.9% during the 4th quarter. Boothbay Fund Management LLC now owns 27,445 shares of the company's stock worth $116,000 after purchasing an additional 77,445 shares in the last quarter. Finally, ProShare Advisors LLC lifted its holdings in DocGo by 49.0% during the 4th quarter. ProShare Advisors LLC now owns 28,641 shares of the company's stock worth $121,000 after purchasing an additional 9,425 shares in the last quarter. Hedge funds and other institutional investors own 56.44% of the company's stock.

DocGo Price Performance

NASDAQ DCGO traded up $0.02 during trading on Friday, reaching $1.59. The company's stock had a trading volume of 344,412 shares, compared to its average volume of 767,313. The stock has a market capitalization of $161.64 million, a PE ratio of -79.25 and a beta of 0.97. The firm has a fifty day moving average of $1.64 and a 200 day moving average of $2.98. DocGo Inc. has a one year low of $1.23 and a one year high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The firm had revenue of $96.03 million for the quarter, compared to the consensus estimate of $104.25 million. DocGo had a negative net margin of 0.12% and a positive return on equity of 2.52%. Research analysts expect that DocGo Inc. will post 0.25 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DCGO has been the topic of a number of recent research reports. BTIG Research cut DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Needham & Company LLC decreased their target price on DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a research note on Friday, May 9th. Finally, Canaccord Genuity Group restated a "hold" rating and issued a $1.45 target price (down from $5.00) on shares of DocGo in a research note on Monday, May 12th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, DocGo presently has a consensus rating of "Moderate Buy" and a consensus price target of $3.56.

Check Out Our Latest Stock Report on DocGo

DocGo Company Profile

(Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

See Also

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines